Securities Law, International Law & Trade, Science, Computers & Technology

New EU rules on online and alternative dispute resolution - a win/win?

by Susan McLean | Morrison & Foerster LLP on 5/15/2013

On 22 April 2013, the Council of the European Union (the “Council”) adopted a regulation on online dispute resolution (“ODR”) and a directive on alternative dispute resolution (“ADR”). Tonio Borg, the EU's Commissioner for...more

LCH.Clearnet Cites ‘Major’ Tech Failure In December

by Elan Mendel | Shipkevich PLLC on 3/26/2013

LCH.Clearnet Ltd., one of the world’s largest interest-rate swap clearinghouse, cited a “major” information technology failure on December 31st of last year. The IT failure affected payment processing in the U.K. and...more

McNulty’s Maxim No. 3 and Response to Allegations of Bribery

by Thomas Fox on 3/26/2013

In a Wall Street Journal (WSJ) article by Chris Matthews, Joe Palazzolo and Shira Ovide, entitled “U.S. Probes Microsoft Bribery Allegations”, they reported that the Department of Justice (DOJ) and Securities and Exchange...more

Mind the Gap - LSE announces plans for new High Growth Segment

by Alex Gibson, James O. Green, Thomas Sibert | K&L Gates LLP on 2/19/2013

Following the announcement last September that the government was encouraging the London Stock Exchange ("LSE") to relax its rules for tech companies, the LSE last week formally announced its plans for a new High Growth...more

London Stock Exchange Publishes Draft Rulebook for New Fast-Growth Segment

by Iain Wright | Morgan Lewis on 2/15/2013

Rulebook sets out criteria for admission to the high-growth segment, which has been designed to meet the needs of fast-growing European companies. On 13 February, the London Stock Exchange (LSE) published a draft...more

Maintaining Our Focus - Winter 2013

by David Rosenblatt, Mark Schonfeld, Matthew Tuttle | Burns & Levinson LLP on 2/15/2013

In This Issue: - Message from the Managing Partner - Amazing Clients®: ACell: Medical Miracles - The Age of Bionic Reconstruction Arrives - Rethinking Today’s “Fixed Income” Investments - Can Gray...more

Transaction Monitoring Under the FCPA [Video]

by Thomas Fox on 1/31/2013

Transaction monitoring was mentioned in a couple of significant enforcement actions of 2012. I think that it will move to becoming a best practice in FCPA compliance programs. This video will explain how transaction...more

Three Important Lessons from the FCPA Guidance for Pharmaceutical and Medical Device Companies

by Michael Volkov on 12/5/2012

The US Chamber of Commerce “praised” the FCPA Guidance. The Chamber did not get what it wanted but it had to recognize that the FCPA Guidance was helpful for businesses. The FPCA Guidance provides important information for...more

BIS Report on the Future of Computer Trading in Financial Markets

by Orrick - Structured Finance Group on 11/8/2012

On October 23, the Department for Business, Innovation and Skills published a report entitled ‘The Future of Computer Trading in Financial Markets – An International Perspective’. The report is an analysis of the potential...more

ESMA Publishes Draft EMIR Technical Standards

by McDermott Will & Emery on 10/9/2012

On 27 September 2012, the European Securities and Markets Authority (ESMA) published its draft technical standards in the European Market Infrastructure Regulation (EMIR). The technical standards supplement the level one text...more

China Life Sciences and Health Industry Client Briefing – September 2012 (October 4, 2012)

by Reed Smith on 10/5/2012

In This Issue: • Merck-Simcere Joint Venture Starts Business in Pudong (Shanghai Daily 2012-09-13) – September 14, 2012 • Pfizer Joint Venture Set to Hire 600 Staff (Bloomberg News 2012-09-14) – September 14,...more

China 20/20 Legal & Regulatory Developments - September 29, 2012

by Orrick, Herrington & Sutcliffe LLP on 10/1/2012

In This Issue: - 12th Five Year Plan for Financial Industry Development and Reform - 12th Five Year Plan for the Development of Cloud Computing in China - MOFCOM Establishes Administrative Office for Commercial...more

Profit Counting: The Pfizer FCPA Settlement

by Sheppard Mullin Richter & Hampton LLP on 8/20/2012

On August 8, 2012, the U.S. Department of Justice (“DOJ”) and the U.S. Securities and Exchange Commission (“SEC”) announced agreements with the drug manufacturer Pfizer Inc. to settle allegations that a Pfizer subsidiary had...more

July 2012: Japan Litigation Update

by Quinn Emanuel Urquhart & Sullivan, LLP on 7/25/2012

In This Issue: - The IP High Court Addresses Trademark Infringement Liability of Internet Shopping Websites - Japanese SESC Accelerates Its Enforcement Activities - Development on Introduction of a New...more

The FCPA in 2011: Five Answers and a Looming Question

by Sheppard Mullin Richter & Hampton LLP on 2/1/2012

The Department of Justice has been warning the Life Sciences industries - pharmaceutical and medical device companies - of its intent to focus "on the application of the Foreign Corrupt Practices Act"...more

ESMA Consultation on Further Prospectus Directive Technical Advice

by Morrison & Foerster LLP on 12/29/2011

Fresh from delivering its final technical advice to the European Commission on final terms and summaries in the context of the Prospectus Directive Amending Directive (2010/73/EU), the European Securities and Markets...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Securities Law › International Law & Trade › Science, Computers & Technology

New EU rules on online and alternative dispute resolution - a win/win?

LCH.Clearnet Cites ‘Major’ Tech Failure In December

McNulty’s Maxim No. 3 and Response to Allegations of Bribery

Mind the Gap - LSE announces plans for new High Growth Segment

London Stock Exchange Publishes Draft Rulebook for New Fast-Growth Segment

Maintaining Our Focus - Winter 2013

Transaction Monitoring Under the FCPA [Video]

Three Important Lessons from the FCPA Guidance for Pharmaceutical and Medical Device Companies

BIS Report on the Future of Computer Trading in Financial Markets

ESMA Publishes Draft EMIR Technical Standards

China Life Sciences and Health Industry Client Briefing – September 2012 (October 4, 2012)

China 20/20 Legal & Regulatory Developments - September 29, 2012

Profit Counting: The Pfizer FCPA Settlement

July 2012: Japan Litigation Update

The FCPA in 2011: Five Answers and a Looming Question

ESMA Consultation on Further Prospectus Directive Technical Advice

Transaction Monitoring Under the FCPA [Video]

Expand Your Reach